4//SEC Filing
Greco Theresa 4
Accession 0001628280-25-026500
CIK 0001448431other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:04 PM ET
Size
9.1 KB
Accession
0001628280-25-026500
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Greco Theresa
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-05-15+7,042→ 60,356 total - Award
Common Stock
2025-05-15+2,441→ 53,314 total - Award
Stock Option
2025-05-15+12,133→ 12,133 totalExercise: $10.65From: 2026-05-15Exp: 2028-05-15→ Common Stock (12,133 underlying)
Footnotes (3)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest on May 15, 2026, which is the anniversary of the date of the grant.
- [F2]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of the grant.
- [F3]The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001998771
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:04 PM ET
- Size
- 9.1 KB